Doorgaan naar inhoud

Bèta-thalassemie intermedia en minor

Ondersteunende zorg

IJzerchelatie

Iron out for nontransfused thalassemia. (opent nieuw venster)

Marks PW.

Bron‎: Blood 2012;120(5):928-9.

Geïndexeerd‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (opent nieuw venster)

Iron overload in β-thalassemia intermedia: an emerging concern. (opent nieuw venster)

Musallam KM, Cappellini MD, Taher AT.

Bron‎: Curr Opin Hematol 2013;20(3):187-92.

Geïndexeerd‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (opent nieuw venster)

Voedingssupplementen en andere ondersteunende therapieën

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (opent nieuw venster)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Bron‎: Blood 2012;120(7):1531-2.

Geïndexeerd‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (opent nieuw venster)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (opent nieuw venster)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Bron‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Geïndexeerd‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (opent nieuw venster)

Therapeutic roles of curcumin: lessons learned from clinical trials. (opent nieuw venster)

Gupta SC, Patchva S, Aggarwal BB.

Bron‎: AAPS J 2013;15(1):195-218.

Geïndexeerd‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (opent nieuw venster)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (opent nieuw venster)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Bron‎: J Med Assoc Thai 2012;95(1):29-36.

Geïndexeerd‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (opent nieuw venster)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (opent nieuw venster)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Bron‎: Am J Hematol 2013;88(6):503-6.

Geïndexeerd‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (opent nieuw venster)